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Respiratory supercomplexThe ability of phospholipids to act as determinants of membrane protein structure and function is probably
best exempliﬁed by cardiolipin (CL), the signature phospholipid of mitochondria. Early efforts to reconstitute
individual respiratory complexes and members of the mitochondrial carrier family, most notably the ADP/
ATP carrier (AAC), often demonstrated the importance of CL. Over the past decade, the signiﬁcance of CL in
the organization of components of the electron transport chain into higher order assemblies, termed
respiratory supercomplexes, has been established. Another protein required for oxidative phosphorylation,
AAC, has received comparatively little attention likely stemming from the fact that AACs were thought to
function in isolation as either homodimers or monomers. Recently however, AACs have been demonstrated
to interact with the respiratory supercomplex, other members of the mitochondrial carrier family, and the
TIM23 translocon. Interestingly, many if not all of these interactions depend on CL. As the paradigm for the
mitochondrial carrier family, these discoveries with AAC suggest that other members of this large group of
important proteins may be more gregarious than anticipated. Moreover, it is proposed that AAC and perhaps
additional members of the mitochondrial carrier family might represent downstream targets of pathological
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Whereas the importance of lipids in maintaining and establishing
membrane barriers is accepted as dogma, the principles that guide
how phospholipids inﬂuence the structure and function of the vast
array of proteins associated with lipid bilayers are still emerging. At itsll rights reserved.most elemental, the lipid bilayer, a mixture of distinct lipid
components, provides the matrix for membrane proteins. It is much
more than simply a random matrix, however; for within this pool of
lipids, speciﬁc protein–lipid interactions occur that have been
demonstrated critical for the structure, incorporation, and/or assem-
bly of proteins, protein complexes, or complexes of protein complexes
[1–8]. The importance of speciﬁc protein–lipid interactions for the
proper functioning of an organelle is perhaps best exempliﬁed by
mitochondria, the predominant (if not exclusive) subcellular location
of the unique phospholipid, cardiolipin (CL).
2060 S.M. Claypool / Biochimica et Biophysica Acta 1788 (2009) 2059–2068CL is unique for at least three reasons. First, CL is almost exclusively
found in association with the mitochondrial inner membrane, the
membrane compartment inwhich it is synthesized. In fact, cardiolipin
synthase, Crd1p, synthesizes CL in the context of the matrix-facing
leaﬂet of the inner membrane [9]. Thus, to obtain its ﬁnal distribution
between both leaﬂets of the inner membrane [10–12], CL must ﬂip to
the intermembrane space apposed leaﬂet [13]. It has not yet been
determined how this is accomplished mechanistically. Also note-
worthy, while the majority of phospholipids are synthesized in a
deﬁned compartment, the endoplasmic reticulum [14], and then
disseminated throughout the cell, CL, by-and-large, remains at its site
of biosynthesis. This would seem to indicate that CL is critically
important for this compartment. As a corollary, it also suggests that CL
may be detrimental to the normal functioning of other membrane-
bound organelles.
Second, as its pseudonym diphosphatidylglycerol implies, CL is a
lipid dimer consisting of two phosphatidyl residues bridged by a
glycerol [15]. Thus, CL has two phosphate headgroups that are
associated at physiologic pH with a single negative charge [16,17]
and four attached fatty acyl chains. While none of the enzymes
involved in the biosynthesis of CL display any acyl chain speciﬁcity
[18,19], the fatty acyl chain proﬁle of CL in a given tissue or organism is
not random, although it is often different in given tissues and
organisms [20,21]. Instead, steady state CL typically contains more
unsaturated fatty acyl chains that exhibit a high degree of molecular
symmetry [20–22]. Thus, newly synthesized CL is remodeled to obtain
its ﬁnal collection of attached fatty acyl chains [23,24]. One pathway ofFig. 1. Assembly of ATP synthase oligomers, the respiratory supercomplex, and AAC2 compl
mitochondria derived fromwild type (+CL) or Δcrd1 (−CL) yeast was resolved by 2D BN/S
AAC2. ⁎ highlights crossreaction with porin of the AAC antiserum. The migrations of the Vdim
appropriate set of panels. The composition of the different AAC2 complexes is indicated abo
dicarboxylate carrier; Ggc, GTP/GDP carrier. The interaction of AAC2 with the indicatedmitoc
size of each complex has not been determined; thus, the order of the depicted AAC2-carrieCL remodeling involves the CL transacylase, tafazzin, the mutant gene
product associated with the X-linked cardioskeletal myopathy, Barth
syndrome [25–28]. The mere presence of a disease that is due to the
absence of an enzyme that mediates CL remodeling suggests the
physiological importance of this process. There are three signiﬁcant
changes in the phospholipid composition of mitochondria in Barth
syndrome patients that confound this conclusion, however. Speciﬁ-
cally, in Barth syndrome patients and models alike [20,22,29–36],
mitochondria contain a reduced steady state level of CL, the remaining
CL is asymmetrical and contains more saturated fatty acyl chains, and
monolyso-CL, the intermediate in the CL remodeling pathway (which
contains only three fatty acyl chains), accumulates. Any or all of these
alterations could contribute to the numerous mitochondrial abnorm-
alities observed in Barth syndrome patients.
Third, CL is a so-called structural phospholipid capable of
vacillating between lamellar and inverted hexagonal structures in
the absence or presence of divalent cations, respectively [37].
Nonbilayer lipids are hypothesized to participate in membrane
curving and fusion events [38,39]. Mitochondria are known to fuse
and divide continuously [40–42]. Furthermore, two morphological
hallmarks of mitochondria, namely cristae of the inner membrane
and contact sites between the inner and outer membrane, are likely
to involve nonbilayer lipid structures. The ability of CL to adopt
nonbilayer hexagonal formations directly relates to its primary
structure. Speciﬁcally, the phosphate headgroups of CL allow binding
of divalent cations while the four attached typically unsaturated
fatty acyl chains give CL a cone-shaped structure. While theexes in the presence and absence of CL. 100 μg of 1.5% (wt/vol) digitonin extracts from
DS-PAGE and immunoblots performed for complex V (F1α/β), complex IV (Cox2p), and
er, Vmonomer, III2IV2, III2IV, and IV supercomplexes are indicated schematically above the
ve the AAC immunoblots. AAC1, ADP/ATP carrier isoform 1; Pic, phosphate carrier; Dic,
hondrial carriers occurred in complexes ranging in size from ∼400 to 160 kDa. The exact
r protein interactions is for illustrative purposes only. Details provided in text.
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not been clearly demonstrated, it is noteworthy that in yeast the
combined absence in mitochondria of phosphatidylethanolamine,
another cone-shaped phospholipid, and CL is synthetically lethal
[43]. Interestingly, changes in the respiratory capacity of mitochon-
dria include signiﬁcant ultrastructural rearrangements of the inner
mitochondrial membrane [44–48]. Moreover, actively respiring yeast
contain more CL than yeast grown on fermentable carbon sources
[30,49,50]. Again, the maintenance of CL in the mitochondrial inner
membrane suggests that these nonbilayer capabilities are a)
important for the normal functioning of the inner membrane, and
b) potentially detrimental to the normal functioning of other
membrane-bound structures.
CL is almost exclusively associated with membranes charged with
the task of generating an electrochemical gradient that is used to
produce ATP. Such membranes include the mitochondrial inner
membrane and the bacterial plasma membrane. The mitochondrial
inner membrane has an unusually high ∼3–4:1 protein:lipid ratio. In
contrast, the protein:lipid ratio of the mitochondrial outer membrane
is ∼1–1.6:1 [51–53]. While the contribution of CL to the establish-
ment of this remarkably high concentration of proteins in the inner
membrane has yet to be demonstrated, it is noteworthy that CL has
the ability to interact with a number of different proteins, including
all of the major players involved in oxidative phosphorylation
[4,6,54–65]. Much recent attention has focused on the importance
of CL for the structural organization of the respiratory complexes in
higher order structures of functional importance [5,7,8]. A modern
appreciation of the importance of CL in the structure and function of
another critical component of the oxidative phosphorylation
machinery, the ADP/ATP carrier (AAC), has ostensibly been forgotten.
A comparison of the assembly status of oligomers of the ATP
synthase, the respiratory supercomplexes, and AAC in wild type
(+CL) and Δcrd1 (−CL) yeast clearly demonstrates the relative
importance of CL for AAC (Fig. 1). Therefore, in this review, I will
brieﬂy discuss the importance of CL in the formation of the
respiratory supercomplexes. I will then turn my attention to the
critical role of CL for the normal structure and function of AAC, the
charter member of the expanding mitochondrial carrier family. Used
as a paradigm for this family of proteins, the demonstrated
importance of CL for AAC biology suggests a general requirement of
CL for the entire mitochondrial carrier family.
2. CL and respiratory supercomplexes
CL interacts with all of the major players in oxidative phosphor-
ylation, including respiratory complexes I, III, IV, and V and the two
members of the mitochondrial carrier family required for this process,
AAC and the phosphate carrier (PiC; [4,6,54–65]). In vitro, CL is
required to fully reconstitute the activity of respiratory complexes I, III,
and IV [58,65]. In contrast, yeast completely devoid of CL retained the
capacity to perform oxidative phosphorylation, albeit at a reduced
efﬁciency, under normal conditions [3,66]. However, in the absence of
CL, mitochondria failed to generate ATP under stressful conditions
such as elevated temperatures [66]. Thus, while not absolutely
required for oxidative phosphorylation in vivo, CL increases the
dynamic range of conditions in which this process can occur. Even
under optimal conditions, CL signiﬁcantly enhances the efﬁciency of
energy production.
Respiratory complexes, multisubunit complexes themselves,
assemble in higher order structures referred to generically as
respiratory supercomplexes [67,68]. There are two general types of
supercomplex, those involving components of the electron transport
chain (complexes I, III, and IV) and those assembled using monomeric
complex V (ATP synthase) as its building block. In mammalian
mitochondria, the electron transport chain-containing supercomplex
consists of respiratory complex I associated with a complex III dimerand from one to four copies of complex IV [68,69]. In the yeast Sac-
charomyces cerevisiae which lacks complex I of the electron transport
chain, the equivalent supercomplex is assembled using two complex
IIIs as a central dimer scaffold with either one or two afﬁliated
complex IVs (III2IV2 or III2IV; [68]). Electron transport chain-contain-
ing supercomplexes, herein called respiratory supercomplexes (also
called respirasomes in the literature) are hypothesized to increase the
efﬁciency of substrate channeling between individual complexes (e.g.
cytochrome c between complexes III and IV). Consistent with this
postulate, the respiratory complexes in yeast behave in vivo as a single
functional unit [70]. Moreover, the cooperative activity of yeast
complexes III and IV is lost upon solubilization of mitochondria with
detergents that disrupt the respiratory supercomplex while preser-
ving the integrity of the individual complexes [68]. Both the stability
of the respiratory supercomplex and the in vivo cooperation of the
electron transport chain is compromised in yeast lacking CL [1,5,7,8].
Speciﬁcally, in the absence of CL there is an increased relative
abundance of the small form of the respiratory supercomplex (III2IV)
and free complex IV is detected (Fig. 1 and [1,5]). Importantly, these
structural alterations in supercomplex stability are associated with a
reduced coupling of ATP synthesis to oxygen consumption by the
electron transport chain [1,66,71,72], a commonly employed measure
of the efﬁciency of oxidative phosphorylation. Thus, in yeast lacking
CL, structural alterations in respiratory supercomplexes are observed
that are directly associated with a functional consequence. The
importance of CL for respiratory supercomplex assembly and function
in mammalian mitochondria has not been reported. However, it is
worth mentioning that aberrant respiratory supercomplexes were
observed in ﬁbroblasts derived from Barth syndrome patients [73].
While not a black-and-white situation for the reasons outlined in the
Introduction, these observations do support a general role of CL in
respiratory supercomplex stability in mammalian mitochondria.
Oligomers of the ATP synthase have been observed in yeast and
mammalian mitochondria [68,74]. In contrast to respiratory super-
complexes, ATP synthase oligomerization does not require CL, at
least in yeast (Fig. 1 and [1,5]). Oligomers of the ATP synthase are
critical in the establishment and maintenance of normal cristae
morphology [75–77].
3. AAC and CL
Like other members of the mitochondrial carrier family (also
known as the SLC25 family), AACs are ∼300 amino acid polypeptides
that encode proteins of 28–35 kDa with six transmembrane domains
and a three-fold pseudosymmetry [78]. Of this large family (∼50
human genes and 35 yeast genes), only AACs and PiCs are strictly
required for oxidative phosphorylation. AACs (also called ANTs for
adenine nucleotide transporter) mediate the 1:1 exchange of ADP into
and ATP out of the mitochondrial matrix across the inner membrane.
PiCs, either in symport with H+ or antiport with hydroxyl ions,
transport Pi into the matrix. Thus, the combined activity of AACs and
PiCs delivers both substrates (ADP and Pi) that the ATP synthase
utilizes to generate ATP. Moreover, both processes are energetically
costly due to their partial collapse of the electrochemical gradient
established by the electron transport chain. In fact, it has been
estimated that as much as one half of the energy generated by the
electron transport chain is used to drive these two transport pathways
[79]. In addition to this critical physiological activity, AAC and PiC have
been suggested to participate in certain forms of apoptosis which may
depend on the capacity of AAC to form a large Ca2+-stimulated,
slightly cation-selective channel and the ability of both AAC and PiC to
associate with additional mitochondrial proteins implicated in the
formation of the mitochondrial permeability transition pore [80–82].
Furthermore, mutated AACs are associated with AAC1 deﬁciency,
Senger's syndrome, and certain forms of autosomal dominant and
recessive progressive external ophthalmoplegia [83–87]. A mutation
2062 S.M. Claypool / Biochimica et Biophysica Acta 1788 (2009) 2059–2068in PiC has been observed in two patients with PiC deﬁciency [88].
Consistent with their critical role in oxidative phosphorylation, these
diseases are associated with deﬁcits in energy production.
In yeast and man, three isoforms of AAC have been identiﬁed.
AAC2, the major isoform in yeast (equivalent to the heart and
muscle-speciﬁc human AAC1), is one of the most abundantly
expressed proteins in mitochondria and the only isoform required
for respiration [89]. Initial efforts to purify and reconstitute ADP/ATP
transport suggested the importance of CL for high in vitro activity
[90,91]. Consistent with this notion, six molecules of CL are tightly
bound per AAC dimer [54,92]. Interestingly, it is the headgroup
structure and not the acyl chain composition of CL that promotes the
high afﬁnity interaction between CL and AAC [93,94]. The absolute
importance of CL for AAC function was for a time obscured by the six
tightly bound CL molecules due to the fact that CL was dissociated
only upon AAC denaturation. During a systematic analysis of yeast
AAC2 mutants [95], a mutant harboring a single amino acid
substitution at position 73, C73S, was identiﬁed that subsequently
clariﬁed the importance of CL for AAC function [92]. Speciﬁcally,
while yeast only expressing the C73S AAC2 variant retained the
ability to grow on nonfermentable carbon sources (requiring
functional oxidative phosphorylation), the mutant carrier lacked
any transport activity upon in vitro reconstitution unless CL was
incorporated into the proteoliposomes. The lack of reconstituted
transport in the absence of CL was linked to the speciﬁc loss of most
of the six tightly bound CLs per AAC dimer during the puriﬁcation of
the C73S mutant. Thus, it was concluded that CL indeed was an
“activator” of yeast AAC and possibly AACs from other organisms
and/or other members of the mitochondrial carrier family [92].
As aforementioned, yeast lacking CL entirely are able to grow on
nonfermentable carbon sources while Δaac2 yeast cannot. These
observations alone indicate that AAC2 function does not absolutely
require the presence of CL.
Although not yet thoroughly investigated, four observations
suggest that the ability of CL to activate AACs is not a yeast-speciﬁc
phenomenon. First, puriﬁed beef heart AAC and wild type yeast AAC2
both contain six tightly bound CL molecules per carrier dimer
[54,92]. This suggests a structural homology between yeast and
bovine AACs. Second, four mutations in the heart and skeletal
muscle-speciﬁc isoform of AAC, AAC1, that are associated with
certain types of autosomal dominant and recessive, progressive
external ophthalmoplegia can be modeled in yeast AAC2 [83,86].
Thus, the high degree of structural similarity between yeast AAC2
and human AAC1 is associated with functional similarity as well.
Third, the crystal structure of bovine AAC isolated from heart muscle
mitochondria includes three partially ordered CLs [62]. Fourth,
reconstitution of AAC from rat brain mitochondria requires either
CL or phosphatidylglycerol [96]. One notable difference in the
mitochondrial phospholipid proﬁle in Δcrd1 yeast is the accumula-
tion of phosphatidylglycerol, the precursor of CL [3,5,7,50,97]. Thus,
the ability of AAC2 to function in yeast lacking CL has been explained
by a partial functional compensation by phosphatidylglycerol.
Consistent with this, yeast lacking both phosphatidylglycerol and
CL are unable to grow on nonfermentable carbon sources [98].
Collectively, CL is strongly implicated as being of fundamental
importance for full AAC function. However, what is not known is
how CL “activates” AAC activity and facilitates normal AAC physiol-
ogy. The recently deﬁned AAC2 interactome and the demonstration
of the importance of CL for the AAC2 interactome have started to
provide clues to these pressing questions.
4. AAC monomers or homodimers
In contrast to other components of the oxidative phosphorylation
machinery, the two carrier proteins required for this process, AAC
and PiC, have generally been modeled to work in isolation. Thisreﬂected the consensus that members of the mitochondrial carrier
family exist and function as homodimers [99–110]. Recently, the
laboratory of Kunji has challenged this dogma, providing evidence
that yeast AACs assemble as monomers in mitochondrial membranes
[111,112] and that, in fact, all AAC transport activity can be fulﬁlled by
an AAC monomer [113]. The absence of AAC2 homodimers was
directly determined by the failure of either His6- or HA-epitope
tagged AAC2 constructs to co-afﬁnity purify untagged AAC2 [112].
However, utilizing a similar strategy, Deinhart and Stuart recently
determined that His6-AAC2 did, in fact, co-purify endogenous,
untagged AAC2 [114]. An explanation for these discrepant results is
not immediately apparent.
In a very elegant study, monomeric AAC was demonstrated to be
capable of performing all AAC-mediated transport [113]. The experi-
mental design involved co-expressing two forms of AAC, one sensitive
and one resistant to chemical inhibition. Results would indicate that, if
AAC functions as an obligate homodimer, then the sensitive form of
AAC should be able to act in a dominant-negativemannerwith respect
to the AAC that is otherwise resistant to inhibition. Based on this
rationale, it was concluded that yeast AAC2 functioned as a monomer.
However, there is reason to approach this conclusion with some
hesitation. In these experiments, inhibition of AAC2 function was
achieved using sulfhydryl reagents. Therefore, to generate an AAC2
construct resistant to inhibition by such reagents, all four cysteine
residues in AAC2 were changed to alanine, including that at position
73. As previously discussed, the C73S AAC2 mutant was critical in
deﬁning the importance of CL with respect to AAC transport [92]. The
C73S mutant functioned in vivo but not in vitro unless CL was included
in the assay. A molecular explanation for this dichotomy has not been
provided but it is tempting to hypothesize that it might reﬂect an
important role for CL in AAC2 oligomerization for the following four
reasons. First, during the puriﬁcation of C73S AAC2 most of the tightly
bound CL molecules were lost, explaining the requirement of CL in the
reconstitution assay [92]. This suggests that C73 is somehow involved
in the tight association of CL with AAC. Second, import-assembly
assays demonstrated that yeast AAC1 harboring an equivalent
mutation, C63S, was imported and incorporated into the inner
membrane normally but exhibited impaired assembly [101]. This
implies that this conserved cysteine residue is important for AAC
oligomerization. Third, while the initial crystal structure of bovine
AAC contained only monomers [63], a subsequent crystal structure
included a potential AAC homodimer that was mediated by two
tightly bound CL molecules sandwiched between each AAC monomer
on the matrix side [62]. Fourth, the potential importance and
physiologic relevance of the CL-mediated greasy handshake has
already been suggested. In Δcrd1 yeast, both the assembly of AAC2,
as assessed by 1D blue native (BN)-PAGE, and AAC2 function are
altered [3]. With respect to AAC2 assembly, 1D BN-PAGE immunoblot
analyses of AAC2 following solubilization of wild type yeast
mitochondriawith the mild detergent digitonin revealed the presence
of bands that, based on their mobility, were presumed to represent
AAC2 homodimers and possibly homotetramers [3]. In the absence of
CL, the largest form of AAC2 was not observed, while the most
abundant smaller form, thought to reﬂect AAC2 homodimers,
migrated as a smaller complex. While the molecular composition of
the detected AAC2 adducts was not provided, CL clearly played a
signiﬁcant role in AAC2 assembly and function. Thus, the cysteine-less
AAC2 construct may have had general assembly problems due to a
weakened association with CL. The assembly status of either the C73S
or cysteine-less AAC2 variants as expressed in yeast has not been
documented. Obviously, the issue of whether AACs function as
monomers or homodimers has not been resolved. Furthermore, if
AAC does form homodimers, a potential requirement of CL for this
should be determined. Finally, it is worth mentioning that even if all
AAC transport can be performed as a monomer, which is important in
deciphering the transport mechanism, transport may still occur
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and/or other multisubunit complexes).
5. CL and the AAC2 interactome
Conventional 1D BN-PAGE analyses of yeast AAC2 revealed AAC2
complexes that, based on their size, have been hypothesized to
represent AAC2 homodimers and homotetramers [3]. The possibility
that AAC2 might assemble with other proteins and/or protein
complexes had not been investigated until very recently. Personal
interest in this possibility was sparked upon analyzing AAC2
complexes in both wild type and Δcrd1 yeast mitochondrial extracts
by 2D BN/SDS-PAGE. These analyses revealed the presence of multiple
AAC2 complexes in wild type extracts, including a very large complex
of N669 kDa, and the utter disorganization of AAC2 complexes when
CL is absent (Fig. 1). Utilizing a newly developed dual afﬁnity tag,
AAC2 was demonstrated to interact with the respiratory super-
complex (III2IV2 or III2IV) as well as several other members of the
mitochondrial carrier family, including another isoform of AAC, AAC1,
the phosphate carriers, Pic1p and Pic2p, the dicarboxylate transporter,
Dic1p, and the GTP/GDP transporter, Ggc1p [1]. Importantly, the
interaction of AAC2 with the respiratory supercomplex was simulta-
neously reported by the Stuart laboratory who additionally demon-
strated an association between AAC2 and the TIM23-PAM complex of
themitochondrial innermembrane [114]. The TIM23 translocon is one
of two translocases in the inner membrane involved in the import of
precursor proteins into mitochondria [115]. Consistent with the
signiﬁcant alteration of AAC2 assembly in the absence of CL, the
interaction between AAC2 and the respiratory supercomplex and
AAC2 and the other carrier proteins required CL [1]. An important
point concerning these interactions is that they may each represent
distinct AAC2 complexes with respect to their molecular composition.Fig. 2. The contribution of CL to energy efﬁciency. (A) CL, the “green” phospholipid, facilit
(purple ovals) by stabilizing the III2IV2-AAC2 supercomplex and stimulates AAC (gray squa
electron transport activity of complexes III and IV. (B) In the absence of CL, the absolute a
respiratory supercomplexes, the proton pumping capacity of the electron transport chain is d
chain. © Claypool et al., 2008. Adapted from Fig. 7 originally published in The Journal of CeTherefore, when exploring the physiological signiﬁcance of these
interactions, it is reasonable to discuss them individually. As a CL
requirement for the interaction between AAC2 and the TIM23
translocon has not been demonstrated, this interaction will not be
discussed further. However, it is of interest to note that CL has been
determined to be one of the minimal requirements necessary for
TIM23 function [116].
5.1. The respiratory supercomplex IS super complex
Respiratory supercomplexes are hypothesized to increase the
efﬁciency of electron shuttling between individual respiratory
complexes. CL, although not required for oxidative phosphorylation,
increases the efﬁciency of this process under optimal conditions
[1,3,66]. The decrease in oxidative phosphorylation efﬁciency in the
absence of CL is associated with a partial destabilization of
respiratory supercomplexes [1,5,7,8]. The addition of AAC2 to the
respiratory supercomplex and the demonstration that this physical
association requires CL provides at least two additional mechanisms
by which CL facilitates efﬁcient ATP production. The ﬁrst additional
mechanism focuses on perceived beneﬁts to AAC2 function
resulting from this association (Fig. 2). Another outcome of the
arrangement of respiratory complexes into supercomplexes is that
in addition to increasing their activity, they result in the physical
union of all of the proton-transporting components of the electron
transport chain. Transport of ATP out of and ADP into the matrix is
known to partially collapse the membrane potential due to the
release of ATP and its extra negative charge. Both the directionality
and absolute rate of AAC transport is known to be positively
inﬂuenced by a physiologic electrochemical gradient [117]. The
juxtaposition of AAC2 with respiratory supercomplexes places it in
a microenvironment that is anticipated to maximize AAC2 transportates cyt. c (blue squares) transport between complexes III (cherrywood ovals) and IV
res) activity by placing it in an electrochemical bath provided by the proton-coupled
ctivity of the electron transport chain is reduced due to partial destabilization of the
ecentralized, and AAC2 no longer resides immediately adjacent to the electron transport
ll Biology. doi:10.1083/jcb.200801152.
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Thus, in the absence of CL, the absolute activity of the electron
transport chain is reduced due to partial destabilization of the
respiratory supercomplexes, the proton pumping capacity of the
electron transport chain is decentralized, and AAC2 no longer
resides immediately adjacent to the electron transport chain. If this
rationale is indeed correct, then it might be anticipated that the
phosphate carrier, which is itself energetically costly and required
for oxidative phosphorylation, is also assembled with the respira-
tory supercomplex.
While the perceived beneﬁts of this association for AAC2 function
are admittedly speculative, the importance of the AAC2-respiratory
supercomplex interaction to the proper assembly and function of the
respiratory supercomplex has been demonstrated. In the absence of
AAC2, the assembly of the respiratory supercomplexes is altered and
complex IV activity is speciﬁcally and signiﬁcantly decreased
[1,114,118,119]. Thus, the second new mechanism by which CL
facilitates efﬁcient ATP production is through the AAC2-mediated
promotion of complex IV activity. A molecular explanation for how
AAC2 promotes complex IV activity has not been provided. Based on
the observation that subunits of complex IV are expressed at reduced
levels in Δaac2 yeast [83,114,119], it has been suggested that in the
absence of AAC2, complex IV is speciﬁcally destabilized. However,
another Δaac2 strain maintained normal complex IV subunit
expression even though complex IV activity was signiﬁcantly
decreased [1]. Other explanations for reduced complex IV and
electron transport chain activity have been proposed [83,120].
Pathogenic mutations or absence of AAC2 may cause structural
alterations of the inner membrane and therefore affect electron
transport chain organization and/or activity. Another scenario relates
ATP/ADP imbalance to altered import and assembly of the electron
transport chain complexes [83,121]. While the exact mechanism by
which AAC2 promotes complex IV activity has not been deﬁned, the
importance of CL for this activity is strongly implied based on the
simple fact that CL is required for the interaction between AAC2 and
respiratory supercomplexes [1].5.2. A carrier armada
The identiﬁcation of other mitochondrial carriers in the AAC2
interactome deserves additional attention [1]. First, it indicates that
AAC2 participates in several distinct protein complexes, both in terms
of protein composition as well as complex size. Second, the
interaction between AAC2 and PiCs suggests that the transport of
ADP/ATP and Pi across the inner mitochondrial membrane may be
physically and spatially orchestrated, potentially representing
another example of the substrate channeling phenomenon. As both
ADP and Pi are required by the ATP synthase to harness the proton
gradient established by the electron transport chain, such an
association may increase the efﬁciency of the ATP synthase if theFig. 3. Are AACs and/or other carrier proteins targets of pathological situations associated wi
nature of the alterations in CL are indicated.carriers were in close proximity to complex V. Interestingly, the
interaction of AAC1 and the phosphate carrier was recently
demonstrated in human cells, suggesting that the mixed assembly
of different mitochondrial carriers might be of general physiologic
importance for the mitochondrial carrier family [80]. Third, the
association of AAC2 with several different mitochondrial carriers
(Pic1p, Pic2p, Dic1p, Ggc1p, and AAC1) suggests that in vivo, the
transport of metabolites across the inner membrane might exhibit a
much higher degree of ﬂexibility, cooperation, and coordination than
previously considered. Fourth, CL is important for the interaction of
AAC2 with the other carrier proteins. Based on the postulated
functional beneﬁts provided by the interaction of AAC2 with the
respiratory supercomplexes, CL may also facilitate the placement of
the assorted mitochondrial carriers in an environment that allows
them to function most efﬁciently.6. CL and the mitochondrial carrier family
As a family, the mitochondrial carriers transport a variety of
metabolites across the mitochondrial inner membrane. As such,
members of this family participate in a plethora of basic metabolic
processes that require the cooperative activity of mitochondrial and
cytosolic enzymes (extensively reviewed in [78]). Not surprisingly,
deﬁned human diseases are now known to result from mutations in
several members of this family (comprehensively reviewed in [85]).
All knownmembers of themitochondrial carrier family have the same
basic structure with three ∼100 amino acid domains that collectively
exhibit a three-fold pseudosymmetry. Given the structural and
functional homology of this family, the deﬁned importance of CL for
the assembly and function of yeast AAC2 raises the issue as to whether
other and/or all members of the mitochondrial carrier family depend
to some extent on CL for their full range of physiological activities. This
is not an unprecedented possibility as early efforts to purify and
reconstitute various carrier proteins focused intensively on the
potential contribution of CL [122]. In addition to AAC, the reconsti-
tuted activity of PiC and the carnitine/acylcarnitine transporter were
demonstrated to require CL [57,61,90–92,123–125]. Presumably based
on these studies, CL became a standard addition during the
solubilization and/or reconstitution steps employed in the characteri-
zation of additional members of the mitochondrial carrier family
[126–137]. As a result, direct experimental evidence demonstrating a
potential critical role for CL in the assembly and/or transport activity
of most of the identiﬁed carrier proteins has not been generated. This
omission is all the more glaring as a result of the numerous
unexpected interactions of yeast AAC2 and the importance of CL for
most if not all of these associations [1,114]. If AAC is truly a paradigm
for the mitochondrial carrier family, then other carrier proteins are
likely to be assembling withmore than just themselves and CL is likely
to inﬂuence these associations. As such, it is expected that much basic
biology remains to be discovered.th alterations to CL? Pathologies inwhich alterations in CL have been implicated and the
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The recent revelation that AAC, the most abundant protein in
mitochondria, which for nearly thirty years has been hypothesized to
function in isolation, interacts with the respiratory supercomplex, the
TIM23 translocon, and other members of the carrier family should
serve as a wake-up call that there is a lot to be learned about the
mitochondrial carrier family. What is the assembly status of other
carrier proteins? What is the physiological signiﬁcance of the
association of different mitochondrial carrier proteins? Do carrier
proteins that participate in a common pathway, e.g. the citrate carrier
and the oxoglutarate carrier that are involved in the citrate-malate
shuttle, physically as well as functionally interact? Deﬁning the
interactome for additional carrier proteins will undoubtedly provide
invaluable insight into how the transport of metabolites is integrated
into many basic physiologic processes.
The importance of CL as a determinant of the AAC interactome
should resurrect interest into the relative importance of CL for all of
the other members of the mitochondrial carrier family. With the
recent cloning of the human cardiolipin synthase gene [138–141],
these studies are no longer limited to yeast. It will be of great
interest to determine if mammalian AAC also associates with the
respiratory supercomplex and other carrier proteins and if CL is
critical for these associations. If so, then deﬁcits in AAC function
speciﬁcally and mitochondrial carrier function in general should be
critically evaluated in all of the assorted pathologies that have been
associated with alterations in CL (reviewed in [142]). Examples
include CL peroxidation which has been linked to cytochrome c
release in the early stages of apoptosis [143–145]; CL oxidation,
reduced CL levels, and/or altered molecular composition have been
linked to the mitochondrial dysfunction associated with aging,
ischemia and reperfusion, heart failure, and Barth syndrome
[22,146–151]; deﬁcits in CL synthesis and increased CL catabolism
have been connected to diabetic cardiomyopathy [152]. Consistent
with the concept that AAC may represent a downstream target
subsequent to alterations to CL (Fig. 3), CL peroxidation has been
shown to inactivate mammalian AAC resulting in apoptosis [96].
Future studies should begin to re-address the importance of CL with
respect to carrier protein structure and function and by so doing,
provide insight into their participation in both normal physiological
as well as numerous patho-physiological processes.
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